Alberto Boucas da Silva
Alberto works with our research teams to move promising research projects from the lab into development.
Christine Rommel
Christine is part of the team responsible for making sure CSL’s global network of scientists have access to the data they need to progress medicines efficiently and safely.
Christopher Dumayne
As a principal scientist in CSL’s cardiovascular and renal translational research team, Christopher builds and refines research models that give our therapeutic treatments their best shot at being successful.
Giorgia Jurisic Snijder
As a renal disease area expert at CSL, Giorgia is helping find new medicines to treat rare kidney diseases.
Olga Neumueller
Olga and her team work with health authorities to get new medicines to patients around the world.
Jeremy Casey
Jeremy is leading the clinical trials of the world’s first drug candidate being investigated for the potential reduction of heart attacks in end stage kidney disease patients.
Mollie Barrett
Mollie helps our Research & Development team turn promising science into well executed clinical trials, so we can deliver new, safe and effective medicines to patients as quickly as possible.
Hanna Sundström
Hanna guides promising new therapies through regulatory approvals, translating the science into something health authorities can assess and approve as a new medicine for patients.
Sunil Kumar Raja
Sunil and his team are building a strong foundation of well organised data and analytics platforms to help scientists develop new medicines for rare and serious diseases.